oncology focus Specialized oncology trials strategy firm with access to top KOLs and a network of over 90 leading oncology experts, presenting a valuable partner for sponsors seeking domain expertise and early engagement in trial design and site selection.

niche service Operates unlike traditional CROs by concentrating on trial-specific challenges and delivering targeted, solution-focused strategies rather than full-service execution, suggesting opportunities to partner for gap-filling and risk management.

executive access Cofounded by an oncology KOL and proximity to world-class oncologists offers a compelling channel for high-level sponsor discussions, feasibility assessments, and advisory engagements with senior clinical leadership.

growth potential Small team size and modest revenue indicate room for scalable partnerships, including strategic consulting, pilot projects, or co-development initiatives with larger biopharma or midsize sponsors seeking efficiency in trial planning.

tech & trust Tech stack signals modern, web-enabled workflows and customer feedback emphasis (Trustpilot), suggesting potential for digital collaboration tools, data sharing capabilities, and joint market research to strengthen value proposition.